BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Trigemina 

809B Cuesta Drive
Suite 109
Mountain View  California  94040-3669  U.S.A.
Phone: 650-303-6140 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Trigemina Announces Expansion Of Phase 2 Study Of TI-001 For Chronic Migraine 1/7/2014 9:13:11 AM    More...
Trigemina to Present Nasal Oxytocin Data at Pain Therapeutics Summit East 9/25/2013 9:10:41 AM    More...
Trigemina Presents Data on Intranasal Oxytocin for the Treatment of Trigeminal Neuralgia 8/29/2013 10:16:25 AM    More...
Trigemina to Present at the 2013 International Headache Congress 6/26/2013 9:29:40 AM    More...
Trigemina to Present at the 13th Annual Pain Therapeutics (PTIE) Conference in London 5/20/2013 9:50:18 AM    More...
Trigemina Presents at American Pain Society 32nd Annual Scientific Meeting 5/9/2013 7:10:02 AM    More...
Trigemina to Present at the 2013 Biotechnology Industry Organization (BIO) International Convention 4/22/2013 7:19:47 AM    More...
Trigemina Hosts Clinical Investigator Meeting for Chronic Migraine Study 4/19/2013 8:04:05 AM    More...
Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial 4/8/2013 10:41:34 AM    More...
Trigemina Reports Positive Results with its Lead Compound TI-001 in a Phase IIa Clinical Trial for Chronic Daily Headache 8/11/2010 7:00:38 AM    More...
12

//-->